Johnson & Johnson Seeks Centre's Nod To Test Single-Shot COVID Vaccine

World’s only single-shot COVID-19 vaccine, manufactured by Johnson & Johnson, will soon undergo clinical trials in India. Reportedly, J&J have sought permission from CDSCO (Central Drugs Standard Control Organisation) to start bridging clinical trials with a small number of participants. Moreover, it has partnered with Biological E to broaden its manufacturing in India. Notably, the bridging trials prove only the safety and immunogenicity of a vaccine and not efficacy.